The data presented in this paper are tabulated in the main paper and in the supplementary materials. HIV-1 Env sequences used in Fig. 3 have been deposited in GenBank (accession numbers KJ201545 through KJ201764). Sequences encompassing the full-length viral genome for P5 and P6 have also been deposited in GenBank (accession numbers KJ767573 through KJ767592). This work was supported by NIH grants R37AI64003 and R01AI50111 (to P.D.B.) and R01AI078788 (to T.H.); Deutsche Forschungsgemeinschaft fellowship BI1540/1-1 (to J.B.); the Howard Hughes Medical Institute; and in part with federal funds from the National Cancer Institute, NIH, under contract no. HHSN261200800001E. We thank V. Coalter Martin B. Dorner, 4 Kay Perry, 5 Andreas Rummel, 3 Min Dong, 2 Rongsheng Jin 1 * How botulinum neurotoxins (BoNTs) cross the host intestinal epithelial barrier in foodborne botulism is poorly understood. Here, we present the crystal structure of a clostridial hemagglutinin (HA) complex of serotype BoNT/A bound to the cell adhesion protein E-cadherin at 2.4 angstroms. The HA complex recognizes E-cadherin with high specificity involving extensive intermolecular interactions and also binds to carbohydrates on the cell surface. Binding of the HA complex sequesters E-cadherin in the monomeric state, compromising the E-cadherin-mediated intercellular barrier and facilitating paracellular absorption of BoNT/A. We reconstituted the complete 14-subunit BoNT/A complex using recombinantly produced components and demonstrated that abolishing either E-cadherin-or carbohydrate-binding of the HA complex drastically reduces oral toxicity of BoNT/A complex in vivo. Together, these studies establish the molecular mechanism of how HAs contribute to the oral toxicity of BoNT/A.
B
otulinum neurotoxin serotype A (BoNT/A) (~150 kD) is produced in Clostridium botulinum and, together with the nontoxic non-hemagglutinin (NTNHA) protein and three hemagglutinins (HAs) (HA70, HA33, and HA17, also known as HA3, HA1, and HA2, respectively), forms a large protein complex (1, 2). NTNHA protects BoNT/A from host gastrointestinal destruction by forming a minimally functional progenitor toxin complex (M-PTC) (~290 kD) (3). M-PTC associates with the HAs to form the large PTC (L-PTC) (~760 kD), which exhibits up to 30-fold greater oral toxicity (4-6). Therefore, HAs are critical virulence factors that contribute to the extreme oral toxicity of BoNT/A (7-10). The HAs of BoNT/A (HA/As) assemble into a threefold symmetric hetero-dodecameric complex containing three HA70, three HA17, and six HA33 (~470 kD). The fully assembled HA complex has nine carbohydrate-binding sites, which function by enriching the L-PTC onto cell surfaces in the intestine (Fig. 1A and fig. S1A ) (9, 11). Additional interactions of HAs with the cell-adhesion protein E-cadherin have been reported for the closely related HAs of BoNT serotype B (HA/Bs) (12) , but the molecular mechanism by which HAs exploit E-cadherin and the physiological relevance of this interaction in vivo remain poorly defined. We found that the binding of HA/As to the well-characterized human colorectal adenocarcinoma HT29 cells was greatly reduced when endogenous E-cadherin was knocked down, indicating that the cell-surface binding of HA/As requires E-cadherin (Fig. 1B and fig. S1B ) (Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr. In the mutants, other amino acids were substituted at certain locations; for example, D263A indicates that aspartic acid at position 263 was replaced by alanine) (9) . Binding of these two HA mutants to HT29 cells was similar to that of the wild-type HA complex (HA-WT), further supporting that E-cadherin is largely responsible for the observed cell-surface binding of HAs (Fig. 1C) .
Binding of HAs to cells induces disruption of cell-cell adhesions. This may create a paracellular route for absorption of BoNTs across the intestinal epithelial barriers (12) . Indeed, we observed that binding of HA-WT to HT29 cells for 24 hours severely disrupted cell-cell adhesions, shown by separation of cells (Fig. 1D) . Consistent with their ability to bind HT29 cells, the two carbohydratebinding-deficient mutant HA complexes were still capable of disrupting cell-cell junctions of HT29 cells within 24 hours. Thus, carbohydrate binding is not essential for the HA complex to disrupt cell-cell junctions under these experimental conditions. On the other hand, experiments with a much shorter incubation time (150 min) revealed that the two carbohydratebinding-deficient HA complexes disrupted cellcell junctions much less than HA-WT did ( fig. S1 , C and D), suggesting that carbohydrate binding might enhance disrupting cell-cell junctions, likely by enriching the HA complexes onto cell surfaces and increasing the overall binding avidity. Similar results on cell-surface binding of HA/As and HA-induced cell-cell dissociation were observed on Caco-2 cells, another well-established human epithelial colorectal adenocarcinoma cell line ( fig. S2 ).
How HAs recognize E-cadherin is not known. The ectodomain of E-cadherin mediates selfassembly in adherens junctions, which are crucial intercellular structures maintaining physical association between parallel apposed cells (13) (14) (15) . E-cadherin consists of five tandem extracellular cadherin (EC) domains (EC1 to EC5) (16) , and the most amino-terminal EC1-EC2 domain binds to HA/Bs (12) . We found that the EC1-EC2 of E-cadherin also binds to HA/As with a dissociation constant (K d ) of~2. ), HA17/A, and two HA33/A (Fig. 1A) , is sufficient to bind EC1-EC2 in a 1:1 ratio ( fig. S3B ). The binding affinity of EC1-EC2 to the mini-HA complex (K d~2 .7 mM) is similar to that of the three-arm HA complex, indicating that the mini-HA complex is the minimum Ecadherin-binding unit.
To understand the molecular mechanism underlying the HA-E-cadherin interaction, we determined a 2.4 Å-resolution crystal structure of the mini-HA complex bound to EC1-EC2 of mouse E-cadherin (Fig. 2, A , HA17, and one of the two HA33. No conformational change is observed for the mini-HA complex upon E-cadherin binding (9) . The EC1 and EC2 domains each adopt a seven-stranded b-barrel fold and are connected by a short linker that is maintained in a rigid conformation by the interactions with three calcium atoms (Fig. 2, A and B). Superimposing HA-bound EC1-EC2 to the structure of mouse E-cadherin EC1-EC5 (15) (RMSD 1.57 Å for 206 Ca pairs) shows that the EC3-EC5 extends away from the HA complex (9) and thus is dispensable for HA binding.
Large conformational changes are observed in the amino-terminal region of EC1 upon HA binding (Fig. 2C ). EC1 dimerizes in trans with EC1 of E-cadherin from apposing cells (16) . Specifically, residue Trp 2 acts as an anchor docking into a complementary Trp-binding pocket in the partner E-cadherin molecule (14, 15, 17, 18) , leading to a three-dimensional domain swap within an Ecadherin homodimer (19) . Using analytical ultracentrifugation, we found that EC1-EC2 forms a dimer in solution with a K d of~175.2 mM, which is consistent with previous reports (15, 20) but is markedly weaker than its binding affinity to the HA complex. Strand-swapping in EC1 is believed to be driven by conformational strain in its first 10 aminoterminal residues (termed the A*/A strand), which only arises in its monomeric form (21) . Upon HA binding, the A*/A strand of E-cadherin is pushed back to its monomeric conformation through hydrogen bond interactions between Ser 6-E-cad serves as a hinge that mediates conformational changes necessary for strand swapping (Fig. 2, C and D, and fig.  S4 ) (14) . Therefore, the HA complex stabilizes E-cadherin in the strained monomeric conformation with Trp 2 binding intramolecularly into its own Trp-binding pocket ( Fig. 2C and fig. S4A ). Meanwhile, it physically blocks the E-cadherin trans dimerization by occupying the E-cadherin dimer interface (Fig. 2E) . Moreover, the HA complex also prevents E-cadherin from forming the X-dimer, which is a dimeric intermediate required for the formation of the strand-swapped trans dimer (Fig. 2F) (14, 22) .
Complementing the HA70-EC1 interactions, HA17 interacts with both EC1 and EC2, as well as the Ca 2+ -binding linker (Fig. 2 and fig. S4D ), and one HA33 buries a small hydrophobic interface with EC1. The HA-E-cadherin interaction was abolished when Ca 2+ was chelated by ethylenediaminetetraacetic acid (EDTA) ( fig. S3C) (12) , suggesting that the intertwined interactions among three HAs and two EC domains rely on Ca 2+ -coordination in the EC1-EC2 linker that fixes the relative positioning of the two EC domains. This binding mode contrasts the listerial protein internalin (InlA), which only binds to EC1 in a one-on-one manner (23) . Because E-cadherin's adhesive function depends on Ca 2+ -rigidified connections between successive EC domains (14) , this is yet another example of a pathogen hijacking host cellular function.
To fine-map the HA-E-cadherin binding specificity, we examined binding of the carbohydratebinding-deficient HA 33-DAFA complex to wild-type or mutant mouse E-cadherin ectopically expressed in Chinese hamster ovary (CHO) or human embryonic kidney (HEK) 293 cells, which physiologically do not express E-cadherin (Fig. 3A and  fig. S5 ). The exogenous, wild-type E-cadherin mediated robust binding of the HA 33-DAFA complex to transfected cells, which further demonstrates their direct interaction (Fig. 3A) . When key HA-binding residues on E-cadherin conserved across different species were mutated (for example, K14S and Q23A), the cell-surface binding of the HA 33-DAFA complex was greatly diminished (Fig. 3A) . S4, B and C) . We found that mutating these two residues (for example, K19M or N20R) clearly reduced binding of the HA 33-DAFA complex onto cell surfaces (Fig. 3A) . Consistently, the mini-HA-WT complex did not bind EC1-EC2 that carried these E-cadherin mutants ( fig. S6A ). These mutagenesis studies further confirm the physiological relevance of the HA-E-cadherin interactions observed in the crystal structure.
In contrast to carbohydrate-binding-deficient HA 33-DAFA mutant, the HA-WT complex was still able to bind to cells that expressed E-cadherin mutants tested above ( fig. S5, B and D) . This suggests that the ability of HA-WT complex to bind carbohydrates enhances the overall binding (Fig. 3A and  fig. S5 ). Sequence alignment reveals that all the E-cadherin-binding residues on HA70 and HA17 are conserved between the HAs of BoNT/A and BoNT/B that mediate foodborne botulism in humans, but few are conserved on HAs of BoNT serotypes C and D (HA/C and HA/D), which predominantly cause botulism in birds and cattle. As predicted by our structure, mutating an E-cadherinbinding residue strictly conserved across HA/ A-HA/D, such as D109A HA17/A , abolished its interaction with mouse E-cadherin because of the loss of an intermolecular salt bridge ( fig. S6B) . , and the wild-type HA33/A. Binding of HA-RSDA to HT29 or Caco-2 cells was greatly reduced and failed to disrupt cell-cell junctions (Fig. 3, B and C, and fig.  S2 ). Consistently, the HA-RSDA barely decreased the transepithelial electrical resistance (TER) of the differentiated Caco-2 cell monolayers when applied to the apical or basolateral side (Fig. 3D ) and did not facilitate the paracellular transport of fluorescein isothiocyanate (FITC)-dextran from apical to basolateral compartments as the HA-WT complex did (Fig. 3E) . Together, these data demonstrate that the HA complex disrupts cell-cell junctions through binding to E-cadherin.
On basis of the structures of the HA complex and the full-length ectodomain of mouse E-cadherin (9, 15), we built a complete structural model of the HA-E-cadherin complex, in which three molecules of E-cadherin bind the HA complex (Fig. 4A) . The model shows that the carboxy-terminal EC5 of E-cadherin and the carbohydrate-binding sites on HA33 both point toward the proposed plane of the plasma membrane (Fig. 4B) . Because the crescent shape of EC1-EC5 has considerable conformational flexibility to adopt different curvatures (14, 15) and HA33 also displays a large structural flexibility (9), the HA complex is able to bind to its carbohydrate receptor and protein receptor on the same cell surface (Fig. 4B) . Therefore, these two different types of receptors likely act synergistically to achieve high binding avidity and specificity on the cell surface.
The assembly of the E-cadherin network in adherens junctions (~150 to 300 Å in width) is achieved by a combination of trans-dimerization between cadherins from opposing cell surfaces and cis-dimerization between molecules from the same cell surface ( fig. S7) (14, 15) . We propose that the condensed array of E-cadherin clustering between cells is disrupted by the bulky HA complexes (~260 Å wide and~100 Å height) upon binding. The mini-HA complex bound to HT29 cells weakly and failed to disrupt cell-cell adhesion ( fig. S8) , and neither apical nor basolateral addition of the mini-HA complex disrupted the tight junctions of polarized Caco-2 cell monolayer (9). These results suggest that multivalent binding to carbohydrates and E-cadherin in the context of the triskelion-shape of the full HA complex is necessary to ensure its function. Furthermore, the HA complex may destabilize adherens junctions by affecting E-cadherin homeostasis because the organization of individual adherens junction is highly dynamic where E-cadherin is actively turned over (24) .
Given the observed cellular consequences of HA-E-cadherin interactions, we determined the physiological relevance of HA-E-cadherin and HAcarbohydrate interactions to the oral toxicity of BoNT/A in vivo. This question was directly addressed by comparing the oral toxicity of BoNT/A L-PTC (L-PTC/A) containing HA-WT versus mutant HA complex. To do so, we developed a protocol to reconstitute the complete L-PTC/A, composed of a total of 14 proteins (~760 kD), using recombinant components expressed in Escherichia coli (fig. S9 ). This allowed us to compare L-PTC/As that were all constructed in the same way and contained the same active BoNT/A, with either HA-WT or mutant HA complex. The mouse oral toxicity of the reconstituted wildtype L-PTC/A (rL-PTC WT) is similar to native L-PTC/A purified from C. botulinum (10). The rL-PTC RSDA containing mutated HA/As deficient in E-cadherin binding (HA-RSDA) showed a greatly reduced oral toxicity as compared with that of the rL-PTC WT under the same assay conditions (Fig. 3F) . Thus, the ability of HA complex to bind E-cadherin and disrupt cell-cell junctions is critical for the oral toxicity of BoNT/A in vivo. We also observed a drastic reduction in oral toxicity for the rL-PTC DAFA/TPRA comprising a HA complex deficient in carbohydrate binding (a combination of HA 33-DAFA and HA 70-TPRA ) ( Fig.  3F ) (9) , demonstrating that binding of HA complex to carbohydrates is also important to facilitate BoNT/A absorption in vivo, likely by enriching L-PTC/A onto cell surfaces. Together, these results establish the physiological relevance of HA-E-cadherin and HA-carbohydrate interactions to the extreme oral toxicity of BoNT/A. Our study also provides a framework to investigate the oral intoxication of some HA-less BoNTs (such as BoNT/A2, BoNT/E, and BoNT/F), which instead contain several orfX proteins, whose expression and function are still unknown (2, 25) .
On the basis of the work described previously and presented here, we suggest the following model (Fig. 4C) . The abundant carbohydrates accumulate L-PTCs on the surface of the small intestine to initiate absorption (9) . Then, some L-PTC may cross the epithelial cells by means of transcytosis without interfering with the epithelial barrier, which could be mediated either by BoNT or HAs, although the underlying mechanism is not fully understood (Fig. 4C, step 1) (26-28) . Once the HA complexes gain access to the basolateral surface, they specifically bind to E-cadherin and carbohydrates and disrupt E-cadherinmediated cell-to-cell adhesion (Fig. 4C, step 2) , opening up the paracellular route for BoNT absorption (Fig. 4C, step 3) .
BoNTs are the most potent bacterial toxins known. Our findings reveal the targeting of a host protein by a component of the toxin complex to achieve efficient absorption through possibly the most challenging route of entry into the circulation of humans or other animals. Understanding this remarkable molecular machinery not only provides new targets for therapeutic intervention against oral BoNT intoxication, but also could potentially guide the development of new adherens junction modulators to enhance the permeability of the intestinal epithelium so as to facilitate drug delivery. The importance, extent, and mode of interspecific gene flow for the evolution of species has long been debated. Characterization of genomic differentiation in a classic example of hybridization between all-black carrion crows and gray-coated hooded crows identified genome-wide introgression extending far beyond the morphological hybrid zone. Gene expression divergence was concentrated in pigmentation genes expressed in gray versus black feather follicles. Only a small number of narrow genomic islands exhibited resistance to gene flow. One prominent genomic region (<2 megabases) harbored 81 of all 82 fixed differences (of 8.4 million single-nucleotide polymorphisms in total) linking genes involved in pigmentation and in visual perception-a genomic signal reflecting color-mediated prezygotic isolation. Thus, localized genomic selection can cause marked heterogeneity in introgression landscapes while maintaining phenotypic divergence.
G enomic studies increasingly appreciate the importance of interspecific gene flow in the context of species diversification (1, 2), including that of hominids (3). Yet our understanding of the forces generating heterogeneity in differentiation across the genome and their relationship to phenotypic evolution is limited (3) (4) (5) . The European hybrid zone between all-black carrion crows [Corvus (corone) corone] and gray-coated hooded crows [C. (corone) cornix] (6) provides ideal conditions for studying the evolutionary consequences of introgression in a phase of early species divergence. The geographical distribution pattern of these species suggests a population history shaped by glaciation cycles during the Pleistocene, when periods of isolation in distinct southern refugia alternated with periods of range expansion and secondary contact (7) . The near-absence of neutral genetic differentiation across the hybrid zone (8) strongly contrasts with abrupt spatial segregation of plumage coloration (Fig. 1) , which has remained remarkably stable over the past century despite successful backcrossing of hybrids (6) . Evidence for color-assortative mating (9) and the independent recurrence of pied plumage phenotypes in the otherwise all-black genus Corvus has prompted the hypothesis that this color polymorphism is promoting speciation (fig. S1 ).
We assembled a high-quality reference genome of one hooded crow male sequenced to 152× coverage (table S1). The final assembly consisted of 1298 scaffolds with an N50 size of 16.4 Mb (10) and a cumulative length of 1.04 Gb, including 3.52% gaps; 95% of the assembly was contained within the 100 largest scaffolds (size range: 1 to 50 Mb), which approached chromosome size (crow karyotype: 2n = 80; size range of zebra finch chromosomes: 1 to 156 Mb) ( fig. S2, A and B, and table S2). Evidence-based annotation of the genome with mRNA sequencing data (table S3) identified a set of 20,794 protein-coding genes.
We subsequently resequenced 60 genomes of unrelated individuals from two populations each of carrion and hooded crows (Fig. 1) to a mean sequence coverage of 12.2× (range: 7.1× to 28.6×, table S4); 8.44 million single-nucleotide polymorphisms (SNPs) segregated across all four populations, 5.27 million of which were shared between carrion and hooded crows. Several lines of evidence suggest substantial genome-wide gene flow across the hybrid zone. The major axes of genetic variation (accounting for 11.5% of the total variance) coincided with the presumed direction of spatial expansion out of Spain, yet German carrion crows clustered more closely with both hooded crow populations [ Fig. 1 ; for pairwise fixation index (F ST ) estimates see Fig. 2A fig. S6) , and coalescence-based parameter estimates of an isolation-with-migration model ( fig. S7 ). Consistent with a scenario of admixture upon secondary contact, all populations but Spain showed signatures of expansion and had higher nucleotide diversity than that of the presumably refugial Spanish population (table S5) .
The low genome-wide differentiation across the hybrid zone was also reflected in gene expression divergence as measured by mRNA sequencing (RNA-seq) from 19 individuals and five tissues under controlled conditions. The overall proportion of differentially expressed genes between carrion and hooded crows was low, between 0.03% and 0.41% across tissues [ Fig. 3B ; see (8) ; false discovery rate <0.05]. The main difference in gene expression patterns corresponded to phenotypic divergence in plumage coloration. Differentially expressed genes predominated in growing feather follicles from the torso, where carrion crows produce black feathers and hooded crows gray feathers ( Figs. 1 and 3A ; c 2 df=4 = 169.34, P < 0.001), with an overrepresentation of genes in the melanogenesis pigmentation pathway (Fig.  3 , B and C; n = 21, c 2 df=4 = 147.16, P < 0.001; see table S7 for Gene Ontology terms). Nineteen of 20 differentially expressed melanogenesis-related genes were underexpressed in the gray hooded crow torso (table S8) . The pathway-wide pattern of reduced expression could not be attributed to differences in melanocyte density (Fig. 4) , but rather to upstream regulatory changes inducing broad-scale down-regulation in follicles producing gray feathers (Fig. 3C) .
We surveyed the landscape of genomic divergence with a window-based approach based on population genetic summary statistics derived for 22,072 nonoverlapping 50-kb windows ( Fig.  2A and fig. S8 ) and a hypothesis-free clustering
